<VariationArchive VariationID="2585955" VariationName="NM_001458.5(FLNC):c.985_986dup (p.Asn329fs)" VariationType="Duplication" Accession="VCV002585955" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2023-10-28" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2753515" VariationID="2585955">
      <GeneList>
        <Gene Symbol="FLNC" FullName="filamin C" GeneID="2318" HGNC_ID="HGNC:3756" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q32.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="128830406" stop="128859272" display_start="128830406" display_stop="128859272" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="128470482" stop="128499327" display_start="128470482" display_stop="128499327" Strand="+" />
          </Location>
          <OMIM>102565</OMIM>
          <Haploinsufficiency last_evaluated="2021-07-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNC">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-07-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FLNC">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_001458.5(FLNC):c.985_986dup (p.Asn329fs)</Name>
      <CanonicalSPDI>NC_000007.14:128838001:AA:AAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q32.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="128838001" stop="128838002" display_start="128838001" display_stop="128838002" variantLength="2" positionVCF="128838001" referenceAlleleVCF="C" alternateAlleleVCF="CAA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="128478055" stop="128478056" display_start="128478055" display_stop="128478056" variantLength="2" positionVCF="128478055" referenceAlleleVCF="C" alternateAlleleVCF="CAA" />
      </Location>
      <ProteinChange>N329fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.128478056_128478057dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.128478056_128478057dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.128838002_128838003dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.128838002_128838003dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011807.1" sequenceAccession="NG_011807" sequenceVersion="1" change="g.12574_12575dup">
            <Expression>NG_011807.1:g.12574_12575dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127487.2" sequenceAccession="NM_001127487" sequenceVersion="2" change="c.985_986dup">
            <Expression>NM_001127487.2:c.985_986dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120959.1" sequenceAccession="NP_001120959" sequenceVersion="1" change="p.Asn329fs">
            <Expression>NP_001120959.1:p.Asn329fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001458.5" sequenceAccession="NM_001458" sequenceVersion="5" change="c.985_986dup" MANESelect="true">
            <Expression>NM_001458.5:c.985_986dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001449.3" sequenceAccession="NP_001449" sequenceVersion="3" change="p.Asn329fs">
            <Expression>NP_001449.3:p.Asn329fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001458.4" sequenceAccession="NM_001458" sequenceVersion="4" change="c.985_986dupAA">
            <Expression>NM_001458.4:c.985_986dupAA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_870" sequenceAccession="LRG_870">
            <Expression>LRG_870:g.12574_12575dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_870t1" sequenceAccession="LRG_870t1">
            <Expression>LRG_870t1:c.985_986dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_870p1" sequenceAccession="LRG_870p1" change="p.Asn329Lysfs">
            <Expression>LRG_870p1:p.Asn329Lysfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001458.5(FLNC):c.985_986dup (p.Asn329fs) AND Cardiovascular phenotype" Accession="RCV003368105" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001458.5(FLNC):c.985_986dup (p.Asn329fs) AND multiple conditions" Accession="RCV003777447" Version="1">
        <ClassifiedConditionList TraitSetID="39888">
          <ClassifiedCondition DB="MedGen" ID="CN239310">Dilated Cardiomyopathy, Dominant</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3279722">Distal myopathy with posterior leg and anterior hand involvement</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4310749">Hypertrophic cardiomyopathy 26</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1836050">Myofibrillar myopathy 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-07" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-10-28" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">27908349</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="39888" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16113" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myopathy, distal, 4</ElementValue>
                <XRef ID="Myopathy%2C+distal%2C+4/8952" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WILLIAMS DISTAL MYOPATHY</ElementValue>
                <XRef Type="MIM" ID="614065" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Distal myopathy with posterior leg and anterior hand involvement</ElementValue>
                <XRef ID="MONDO:0013550" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MPD4</ElementValue>
                <XRef Type="MIM" ID="614065" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16666" />
                <XRef ID="16666" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Williams distal myopathy is an autosomal dominant slowly progressive muscular disorder characterized by distal muscle weakness and atrophy affecting the upper and lower limbs. Onset occurs around the third to fourth decades of life, and patients remain ambulatory even after long disease duration. Muscle biopsy shows nonspecific changes with no evidence of rods, necrosis, or inflammation (summary by Duff et al., 2011).
Mutation in the FLNC gene can also cause myofibrillar myopathy-5 (MFM5; 609524), which shows a different pattern of muscle involvement and different histologic changes.</Attribute>
                <XRef Type="MIM" ID="614065" DB="OMIM" />
              </AttributeSet>
              <XRef ID="63273" DB="Orphanet" />
              <XRef ID="C3279722" DB="MedGen" />
              <XRef ID="MONDO:0013550" DB="MONDO" />
              <XRef Type="MIM" ID="614065" DB="OMIM" />
            </Trait>
            <Trait ID="35841" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cardiomyopathy, familial hypertrophic, 26</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy 26</ElementValue>
                <XRef ID="MONDO:0014883" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMH26</ElementValue>
                <XRef Type="MIM" ID="617047" DB="OMIM" />
              </Symbol>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="75249" DB="Orphanet" />
              <XRef ID="C4310749" DB="MedGen" />
              <XRef ID="MONDO:0014883" DB="MONDO" />
              <XRef Type="MIM" ID="617047" DB="OMIM" />
            </Trait>
            <Trait ID="1288" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Filaminopathy (type)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FILAMINOPATHY, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="609524" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myofibrillar myopathy, filamin C-related</ElementValue>
                <XRef ID="Myofibrillar+myopathy%2C+filamin+C-related/8942" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Myofibrillar myopathy 5</ElementValue>
                <XRef ID="MONDO:0012289" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MFM5</ElementValue>
                <XRef Type="MIM" ID="609524" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17062" />
                <XRef ID="17062" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="171445" DB="Orphanet" />
              <XRef ID="C1836050" DB="MedGen" />
              <XRef ID="MONDO:0012289" DB="MONDO" />
              <XRef Type="MIM" ID="609524" DB="OMIM" />
            </Trait>
            <Trait ID="36507" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dilated Cardiomyopathy, Dominant</ElementValue>
                <XRef ID="282032" DB="Illumina Laboratory Services, Illumina" />
              </Name>
              <XRef ID="CN239310" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8550320" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="21606125|MedGen:C3279722;CN239310;C1836050;C4310749" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004594058" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27908349</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with FLNC-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn329Lysfs*23) in the FLNC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FLNC are known to be pathogenic (PMID: 27908349).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLNC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.128478055_128478056insAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3279722" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN239310" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1836050" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4310749" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7582008" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="a8835952|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004054495" DateUpdated="2024-05-01" DateCreated="2023-10-28" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.985_986dupAA pathogenic mutation, located in coding exon 6 of the FLNC gene, results from a duplication of AA at nucleotide position 985, causing a translational frameshift with a predicted alternate stop codon (p.N329Kfs*23). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on the supporting evidence, this variant is expected to be causative of FLNC-related dilated cardiomyopathy; however, its clinical significance for FLNC-related hypertrophy/restrictive cardiomyopathy and/or skeletal myopathy is unclear.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FLNC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001458.4:c.985_986dupAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough091523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8550320" TraitType="Disease" MappingType="XRef" MappingValue="C4310749" MappingRef="MedGen">
        <MedGen CUI="C4310749" Name="Hypertrophic cardiomyopathy 26" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7582008" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8550320" TraitType="Disease" MappingType="XRef" MappingValue="C3279722" MappingRef="MedGen">
        <MedGen CUI="C3279722" Name="Distal myopathy with posterior leg and anterior hand involvement" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8550320" TraitType="Disease" MappingType="XRef" MappingValue="CN239310" MappingRef="MedGen">
        <MedGen CUI="CN239310" Name="Dilated Cardiomyopathy, Dominant" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8550320" TraitType="Disease" MappingType="XRef" MappingValue="C1836050" MappingRef="MedGen">
        <MedGen CUI="C1836050" Name="Myofibrillar myopathy 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

